This company has been acquired
Chembio Diagnostics Future Growth
Future criteria checks 0/6
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 16.2% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Chembio gets $3.2M contract from CDC to develop rapid test for syphilis
Sep 06Chembio stock rises 13% amid plans to develop rapid test for monkeypox
Aug 16Is Chembio Diagnostics (NASDAQ:CEMI) Using Debt In A Risky Way?
Nov 30
Analysts' Revenue Estimates For Chembio Diagnostics, Inc. (NASDAQ:CEMI) Are Surging Higher
Aug 08Does Chembio Diagnostics (NASDAQ:CEMI) Have A Healthy Balance Sheet?
Jul 22Chembio Diagnostics EPS beats by $0.10, beats on revenue
May 06Is Chembio Diagnostics (NASDAQ:CEMI) Using Debt Sensibly?
Apr 07Is Chembio Diagnostics, Inc.'s (NASDAQ:CEMI) Shareholder Ownership Skewed Towards Insiders?
Jan 16Chembio stock gains after COVID-19 tests nab European Union nod
Jan 14Is Chembio Diagnostics (NASDAQ:CEMI) Weighed On By Its Debt Load?
Dec 12
Chembio slumps 13% on delay of U.S. nod for coronavirus antibody test
Dec 04Chembio nabs BARDA contract for rapid respiratory antigen panel test
Dec 02In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Chembio Diagnostics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2022 | 50 | -23 | -14 | -13 | N/A |
| 9/30/2022 | 60 | -36 | -19 | -17 | N/A |
| 6/30/2022 | 61 | -36 | -21 | -20 | N/A |
| 3/31/2022 | 58 | -38 | -29 | -28 | N/A |
| 12/31/2021 | 48 | -34 | -33 | -31 | N/A |
| 9/30/2021 | 37 | -27 | -31 | -29 | N/A |
| 6/30/2021 | 36 | -26 | -30 | -27 | N/A |
| 3/31/2021 | 34 | -25 | -25 | -20 | N/A |
| 12/31/2020 | 32 | -26 | -23 | -19 | N/A |
| 9/30/2020 | 29 | -22 | -21 | -17 | N/A |
| 6/30/2020 | 28 | -21 | -14 | -9 | N/A |
| 3/31/2020 | 33 | -16 | -14 | -10 | N/A |
| 12/31/2019 | 34 | -14 | -13 | -9 | N/A |
| 9/30/2019 | 35 | -13 | -15 | -11 | N/A |
| 6/30/2019 | 37 | -11 | -16 | -14 | N/A |
| 3/31/2019 | 35 | -10 | -16 | -14 | N/A |
| 12/31/2018 | 35 | -8 | -13 | -12 | N/A |
| 9/30/2018 | 33 | -7 | -6 | -5 | N/A |
| 6/30/2018 | 30 | -5 | -5 | -5 | N/A |
| 3/31/2018 | 25 | -5 | -4 | -3 | N/A |
| 12/31/2017 | 24 | -6 | -6 | -5 | N/A |
| 9/30/2017 | 22 | -7 | -9 | -8 | N/A |
| 6/30/2017 | 18 | -8 | -9 | -8 | N/A |
| 3/31/2017 | 18 | -15 | -8 | -8 | N/A |
| 12/31/2016 | 18 | -13 | -7 | -7 | N/A |
| 9/30/2016 | 18 | -11 | N/A | -1 | N/A |
| 6/30/2016 | 21 | -10 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if CEMI's forecast earnings growth is above the savings rate (2.1%).
Earnings vs Market: Insufficient data to determine if CEMI's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if CEMI's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if CEMI's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if CEMI's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CEMI's Return on Equity is forecast to be high in 3 years time